The FSHR Expression in Head and Neck Squamous Cell Cancer. A Pilot Immunohistochemical Study
Language English Country Greece Media print
Document type Journal Article
PubMed
31892586
DOI
10.21873/anticanres.13959
PII: 40/1/349
Knihovny.cz E-resources
- Keywords
- FSHr, HNSCC, histopathology, immunohistochemistry, neoangiogenesis,
- MeSH
- Squamous Cell Carcinoma of Head and Neck metabolism MeSH
- Immunohistochemistry MeSH
- Humans MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Pilot Projects MeSH
- Receptors, FSH metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Receptors, FSH MeSH
BACKGROUND/AIM: Follicle-stimulating hormone receptor (FSHr), expressed on endothelial cells of vessels in different malignant tumors, has been recently investigated as a potential pan-receptor of cancer treatment. However, the expression of this receptor has also been confirmed in other tissues under pathological conditions including cancer. The aim of the presented pilot study was to evaluate the expression of FSHr in head and neck squamous cancer (HNSCC). PATIENTS AND METHODS: A total of 28 HNSCC patient samples were immunohistochemically analyzed for the presence of FSHr using a commercially available primary antibody. RESULTS: FSHr was detected not only in the tumor tissue, but also in the basal layer or dysplastic parts of squamous mucosa and also in fibroblasts surrounding the tumor tissue. CONCLUSION: FSHr is present on different benign or malignant mesenchymal and epithelial structures in HNSCC. A brief literature review revealed a wider role of FSHr in the development of neoplasia.
References provided by Crossref.org
